The U.S. House Committee on Energy and Commerce has been investigating the local pharmaceutical wholesaler since September when it asked for documents related to its shipments, the removal of its CEO and its response to the Drug Enforcement Administration’s attempt to revoke its wholesaler license.
RELATED: Who’s really controlling your drug prices? 5 things to know
The data was provided to Congress by the firm, which acts as a middleman between drug makers and retail pharmacies and has been under scrutiny for its possible role in the opioid overdose crisis that claimed 884 lives in West Virginia alone in 2016.
About the Author